The Effect of CPAP Treatment on Cognitive Functions, Anxiety, and Affective Symptoms
The Effect of Positive Pressure Therapy (CPAP) in Patients With Obstructive Sleep Apnea on Cognitive Functions, Anxiety, and Affective Symptoms
1 other identifier
observational
100
1 country
1
Brief Summary
Long term, prospective study of continuous positive airway pressure treatment influence on cognitive functions in patients with obstructive sleep apnea syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 15, 2019
CompletedFirst Submitted
Initial submission to the registry
February 18, 2019
CompletedFirst Posted
Study publicly available on registry
March 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedNovember 2, 2022
November 1, 2022
5.3 years
February 18, 2019
November 1, 2022
Conditions
Outcome Measures
Primary Outcomes (5)
Change of affective symptoms after 1 year of PAP treatment
Statistically significant change in the scores of Beck Depression Inventory. The total score is calculated as a sum of 21 multiple choice items. Score 0-9: indicates minimal depression, 10-18: indicates mild depression, 19-29: indicates moderate depression, 30-63: indicates severe depression.
1 year of PAP treatment
Change of anxiety symptoms after 1 year of PAP treatment
Statistically significant change in the scores of Beck Anxiety Inventory over the 1-year period of PAP treatment. The total score is calculated as a sum of the 21 items. Score of 0-21 = low anxiety. Score of 22-35 = moderate anxiety. Score of 36 and above = potentially concerning levels of anxiety.
1 year of PAP treatment
Change in Controlled Oral Word Association Test after 1 year of PAP treatment
Statistically significant change in results of Controlled Oral Word Association Test in comparison with the pre-treatment results. Controlled Oral Word Association Test measures spontaneous production of words beginning with some designated letter. For each of three given letters patient has 1 minute to produce as much words as possible. Total count of words will be compared, the higher count of words represents better outcome. Standardized population norms adjusted for age and education will be used to assess the results.
1 year of PAP treatment
Change in d2 Test after 1 year of PAP treatment
Statistically significant change in results of d2 Test in comparison with the pre-treatment results. d2 Test of attention is standardized test of selective and sustained attention and visual scanning speed. Results are measured as a number of mistakes made in 14 lines of symbols, in which patients mark three given symbols. Patient has 20 seconds for each line. Higher number of mistakes represents worse outcome as it points to cognitive impairment. Standardized population norms will be used to assess the results.
1 year of PAP treatment
Change in Trail making test after 1 year of PAP treatment
Statistically significant change in results of Trail making test in comparison with the pre-treatment results. Trail making test is measured in seconds as a time needed to complete trail from first to last point. Higher performing times represent worse outcomes as it points to cognitive impairment. Standardized population norms adjusted for age will be used to assess the results.
1 year of PAP treatment
Secondary Outcomes (8)
Performance in Controlled Oral Word Association Test in untreated OSA patients compared to population norms.
1 year of PAP treatment
Performance in d2 Test in untreated OSA patients compared to population norms.
1 year of PAP treatment
Performance in Trail making test in untreated OSA patients compared to population norms.
1 year of PAP treatment
The difference between compliant and non-compliant patients in affective symptoms after 1 year follow up.
1 year of PAP treatment
The difference between compliant and non-compliant patients in anxiety symptoms after 1 year follow up.
1 year of PAP treatment
- +3 more secondary outcomes
Study Arms (1)
CPAP group
Obstructive sleep apnea patients treated with continuous positive airway pressure
Interventions
Eligibility Criteria
Patients with newly diagnosed obstructive sleep apnea indicated for positive airway pressure treatment
You may qualify if:
- Newly diagnosed obstructive sleep apnea indicated for positive airway pressure therapy, i.e. Apnea-Hypopnea index AHI\> 15
You may not qualify if:
- Psychiatric treatment
- Treatment with psychoactive drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Olomouc
Olomouc, 77900, Czechia
Related Publications (7)
Bixler EO, Vgontzas AN, Lin HM, Ten Have T, Leiby BE, Vela-Bueno A, Kales A. Association of hypertension and sleep-disordered breathing. Arch Intern Med. 2000 Aug 14-28;160(15):2289-95. doi: 10.1001/archinte.160.15.2289.
PMID: 10927725RESULTReichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med. 2005 Dec 15;172(12):1590-5. doi: 10.1164/rccm.200504-637OC. Epub 2005 Sep 28.
PMID: 16192452RESULTHobzova M, Prasko J, Vanek J, Ociskova M, Genzor S, Holubova M, Grambal A, Latalova K. Depression and obstructive sleep apnea. Neuro Endocrinol Lett. 2017 Oct;38(5):343-352.
PMID: 29106789RESULTSzaulinska K, Plywaczewski R, Sikorska O, Holka-Pokorska J, Wierzbicka A, Wichniak A, Sliwinski P. Obstructive sleep apnea in severe mental disorders. Psychiatr Pol. 2015;49(5):883-95. doi: 10.12740/PP/32566. English, Polish.
PMID: 26688840RESULTEikermann M, Jordan AS, Chamberlin NL, Gautam S, Wellman A, Lo YL, White DP, Malhotra A. The influence of aging on pharyngeal collapsibility during sleep. Chest. 2007 Jun;131(6):1702-9. doi: 10.1378/chest.06-2653. Epub 2007 Apr 5.
PMID: 17413053RESULTHobzova M, Hubackova L, Vanek J, Genzor S, Ociskova M, Grambal A, Prasko J. Cognitive function and depressivity before and after cpap treatment in obstructive sleep apnea patients. Neuro Endocrinol Lett. 2017 Jul;38(3):145-153.
PMID: 28759181RESULTVanek J, Prasko J, Genzor S, Belohradova K, Visnovsky J, Mizera J, Bocek J, Sova M, Ociskova M. Cognitive Functions, Depressive and Anxiety Symptoms After One Year of CPAP Treatment in Obstructive Sleep Apnea. Psychol Res Behav Manag. 2023 Jun 21;16:2253-2266. doi: 10.2147/PRBM.S411465. eCollection 2023.
PMID: 37366480DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jakub Vanek, MD.
University Hospital Olomouc
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Sleep laboratory, Department of Respiratory Medicine
Study Record Dates
First Submitted
February 18, 2019
First Posted
March 7, 2019
Study Start
February 15, 2019
Primary Completion
June 1, 2024
Study Completion
June 1, 2024
Last Updated
November 2, 2022
Record last verified: 2022-11